Abstract:Chlamydia pneumoniae, an obligate intracellular organism, has a unique biphasic developmental cycle. Chlamydia pneumoniae infection is a complicated process with a wide range of pathogenic types. In addition to causing common respiratory tract infection, C. pneumoniae can cause chronic persistent infection of multiple systems. Chlamydia pneumoniae is closely associated with the occurrence and development of central nervous system diseases. Here, we summarize research progress in the correlation between C. pneumoniae and central nervous system diseases, and provide important information for more reasonable guidance of clinical treatment in the near future.
袁帅, 吴移谋. 肺炎衣原体与中枢神经系统疾病相关性研究进展[J]. 中国人兽共患病学报, 2021, 37(4): 368-372.
YUAN Shuai, WU Yi-mou. Research progress in the correlation of Chlamydia pneumoniae with central nervous system diseases. Chinese Journal of Zoonoses, 2021, 37(4): 368-372.
[1] Hybiske K, Stephens RS.Mechanisms of host cell exit by the intracellular bacterium chlamydia[J]. Proc Natl Acad Sci U S A, 2007,104(27):11430-11435. DOI: 10.1073/pnas.0703218104 [2] Sriram S.Chlamydia pneumoniae infection of the central nervous system[J]. Curr Opin Neurol, 2001,14(3):355-359. DOI: 10.1097/00019052-200106000-00015 [3] MacIntyre A, Hammond CJ, Little CS, et al. Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells[J]. FEMS Microbiol Lett, 2002,217(2):167-172. DOI: 10.1111/j.1574-6968.2002.tb11470.x [4] Schoborg RV.Chlamydia persistence-a tool to dissect chlamydia-host interactions[J]. Microbes Infect, 2011,13(7):649-662. DOI: 10.1016/j.micinf.2011.03.004 [5] Kun D, Xiang-Lin C, Ming Z, et al.Chlamydia inhibit host cell apoptosis by inducing bag-1 via the mapk/erk survival pathway[J]. Apoptosis, 2013,18(9):1083-1092. DOI: 10.1007/s10495-013-0865-z [6] Macintyre A, Abramov R, Hammond CJ, et al.Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells[J]. J Neurosci Res, 2003,71(5):740-750. DOI: 10.1002/jnr.10519 [7] Cossu D, Yokoyama K, Hattori N.Bacteria-host interactions in multiple sclerosis[J]. Front Microbiol, 2018,9:2966. DOI: 10.3389/fmicb.2018.02966 [8] Sriram S, Stratton CW, Yao S, et al.Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis[J]. Ann Neurol, 1999,46(1):6-14. [9] Walvoort MT, Testa C, Eilam R, et al. Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable haemophilus influenzae [J]. Sci Rep, 2016,6(39430. DOI: 10.1038/srep39430 [10] Ivanova MV, Kolkova NI, Morgunova EY, et al.Role of chlamydia in multiple sclerosis[J]. Bull Exp Biol Med, 2015,159(5):646-648. DOI: 10.1007/s10517-015-3037-z [11] Layh-Schmitt G, Bendl C, Hildt U, et al.Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis[J]. Ann Neurol, 2000,47(5):652-655. [12] Gieffers J, Pohl D, Treib J, et al.Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis[J]. Ann Neurol, 2001,49(5):585-589. [13] Aghaei M, Ashtari F, Bahar M, et al.Chlamydia pneumoniae seropositivity in iranian patients with multiple sclerosis: A pilot study[J]. Neurol Neurochirur Pol, 2011,45(2):128-131. DOI: 10.1016/s0028-3843(14)60023-2 [14] Contini C, Cultrera R, Seraceni S, et al.Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis[J]. Mult Scler, 2004,10(4):360-369. DOI: 10.1191/1352458504ms1049oa [15] Lindsey J, Patel S.Pcr for bacterial 16s ribosomal DNA in multiple sclerosis cerebrospinal fluid[J]. Mult Scler, 2008,14(2):147-152. DOI: 10.1177/1352458507082149 [16] Marrodan M, Alessandro L, Farez MF, et al.The role of infections in multiple sclerosis[J]. Mult Scler, 2019,25(7):891-901. DOI: 10.1177/1352458518823940 [17] McKay KA, Kwan V, Duggan T, et al. Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review[J]. Biomed Res Int, 2015,2015:817238. DOI: 10.1155/2015/817238 [18] Du C, Yao SY, Ljunggren-Rose A, et al.Chlamydia pneumoniae infection of the central nervous system worsens experimental allergic encephalitis[J]. J Exp Med, 2002,196(12):1639-1644. DOI: 10.1084/jem.20020393 [19] Sriram S, Yao SY, Stratton C, et al.Pilot study to examine the effect of antibiotic therapy on mri outcomes in rrms[J]. J Neurol Sci, 2005,234(1/2):87-91. DOI: 10.1016/j.jns.2005.03.042 [20] Aliev G, Priyadarshini M, Reddy VP, et al.Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of alzheimer disease[J]. Curr Med Chem, 2014,21(19):2208-2217. DOI: 10.2174/0929867321666131227161303 [21] Li C, Zhao R, Gao K, et al.Astrocytes: Implications for neuroinflammatory pathogenesis of alzheimer’s disease[J]. Curr Alzheimer Res, 2011,8(1):67-80. DOI: 10.2174/156720511794604543 [22] Balin BJ, Gérard HC, Arking EJ, et al.Identification and localization of Chlamydia pneumoniae in the alzheimer’s brain[J]. Med Microbiol Immunol, 1998,187(1):23-42. DOI: 10.1007/s004300050071 [23] Gérard HC, Dreses-Werringloer U, Wildt KS, et al. Chla-mydophila (chlamydia) pneumoniae in the alzheimer’s brain [J]. FEMS Immunol Med Microbiol, 2006,48(3):355-366. Chlamydophila (chlamydia) pneumoniae in the alzheimer’s brain [24] Al-Atrache Z, Lopez DB, Hingley ST, et al.Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of beta-amyloid found in alzheimer disease[J]. BMC Neurosci, 2019,20(1):6. DOI: 10.1186/s12868-019-0489-5 [25] Little CS, Hammond CJ, MacIntyre A, et al. Chlamydia pneumoniae induces alzheimer-like amyloid plaques in brains of balb/c mice[J]. Neurobiol Aging, 2004,25(4):419-429. DOI: 10.1016/S0197-4580(03)00127-1 [26] Bu XL, Yao XQ, Jiao SS, et al.A study on the association between infectious burden and alzheimer’s disease[J]. Eur J Neurol, 2015,22(12):1519-1525. DOI: 10.1111/ene.12477 [27] Li Y, Tan MS, Jiang T, et al.Microglia in alzheimer’s disease[J]. Biomed Res Int, 2014,2014:437483. DOI: 10.1155/2014/437483 [28] Maccioni RB, González A, Andrade V, et al.Alzheimer's disease in the perspective of neuroimmunology[J]. Open Neurol J, 2018,12:50-56. DOI: 10.2174/1874205X01812010050 [29] Iqbal K, Alonso Adel C, Chen S, et al.Tau pathology in alzheimer disease and other tauopathies[J]. Biochim Biophys Acta, 2005,1739(2/3):198-210. DOI: 10.1016/j.bbadis.2004.09.008 [30] Block J.Alzheimer’s disease might depend on enabling pathogens which do not necessarily cross the blood-brain barrier[J]. Med Hypotheses, 2019,125:129-136. DOI: 10.1016/j.mehy.2019.02.044 [31] Pothineni NVK, Subramany S, Kuriakose K, et al.Infections, atherosclerosis, and coronary heart disease[J]. Eur Heart J, 2017,38(43):3195-3201. DOI: 10.1093/eurheartj/ehx362 [32] Su X, Chen HL. Chlamydia pneumoniae infection and cerebral infarction risk: a meta-analysis [J]. Int J Stroke, 2014,9(3):356-364.s. DOI: 10.1111/ijs.12248 [33] Wohlschlaeger J, Wimmer ML, Nagler DK, et al.Identification of Chlamydia pneumoniae in intracranial and extracranial arteries in patients with stroke and in controls: Combined immunohistochemical and polymerase chain reaction analyses[J]. Hum Pathol, 2005,36(4):395-402. DOI: 10.1016/j.humpath.2005.02.003 [34] Piechowski-Jozwiak B, Mickielewicz A, Gaciong Z, et al.Elevated levels of anti-Chlamydia pneumoniae iga and igg antibodies in young adults with ischemic stroke[J]. Acta Neurol Scand, 2007,116(3):144-149. DOI: 10.1111/j.1600-0404.2007.00819.x [35] Chen J, Zhu M, Ma G, et al.Chlamydia pneumoniae infection and cerebrovascular disease: a systematic review and meta-analysis[J]. BMC Neurol, 2013,13:183. DOI: 10.1186/1471-2377-13-183 [36] Costa CP, Kirschning CJ, Busch D, et al.Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae[J]. Eur J Immunol, 2002,32(9):2460-2470. DOI: 10.1002/1521-4141(200209)32:9<2460::AID-IMMU2460>3.0.CO;2-M [37] Kol A, Sukhova GK, Lichtman AH, et al.Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression[J]. Circulation, 1998,98(4):300-307. DOI: 10.1161/01.cir.98.4.300 [38] Netea MG, Selzman CH, Kullberg BJ, et al.Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells[J]. Eur J Immunol, 2000,30(2):541-549. DOI: 10.1002/1521-4141(200002)30:2<541:AID-IMMU541>3.0.CO;2-X [39] Li B, Xia Y, Hu B.Infection and atherosclerosis: Tlr-dependent pathways[J]. Cell Mol Life Sci, 2020:1-19. DOI: 10.1007/s00018-020-03453-7 [40] Doyle B, Caplice N.Plaque neovascularization and antiangiogenic therapy for atherosclerosis[J]. J Am Coll Cardiol, 2007,49(21):2073-2080. DOI: 10.1016/j.jacc.2007.01.089 [41] Fazio G, Giovino M, Gullotti A, et al.Atherosclerosis, inflammation and Chlamydia pneumoniae[J]. World J Cardiol, 2009,1(1):31-40. DOI: 10.4330/wjc.v1.i1.31 [42] Esenwa CC, Elkind MS.Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke[J]. Nat Rev Neurol, 2016,12(10):594-604. DOI: 10.1038/nrneurol.2016.125 [43] Lucchese G, Floel A, Stahl B.Cross-reactivity as a mechanism linking infections to stroke[J]. Front Neurol, 2019,10:469. DOI: 10.3389/fneur.2019.00469